Scholar Rock Inc., of Cambridge, Mass., reported its $20 million series A financing, which will be used to advance its niche modulators into clinical drug development. Arch Venture Partners, a new investor, led the round with the participation of founding investors, Polaris Partners and Timothy Springer.